Sunday, March 16, 2025
HomeNews

News

Scorpion Biological Services Announces New Kansas Commercial Biomanufacturing Facility

Biopharmaceutical contract development and manufacturing organization (CDMO) Scorpion Biological Services (Scorpion) announced a planned development partnership with a private developer, the State of Kansas,...

Pharming Receives Agreement of Paediatric Investigation Plan and Promising Innovative Medicine designation for leniolisib from UK MHRA

Pharming Group N.V.  announces that it has received a positive decision from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) on a Paediatric...

Protagonist Therapeutics Announces Topline Data from Phase 2 IDEAL Study of PN-943 in Ulcerative Colitis

Protagonist Therapeutics announced topline results from the Phase 2 IDEAL study evaluating PN-943 in patients with moderate-to-severe ulcerative colitis (UC). Also Read: Glass Lewis Proxy...

Biocytogen Signs RenMab/RenLite Licensing Agreement with BeiGene

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") reached an agreement with BeiGene (Beijing) Co., Ltd. for licensing Biocytogen's fully human antibody RenMab/RenLite mice platforms to...

CoNextions TR Tendon Repair System Receives FDA Clearance

CoNextions Inc. , an innovator in tendon repair, is pleased to announce that CoNextions TR Tendon Repair System has received FDA 510(k) Clearance. Expected...
0FansLike
0FollowersFollow
spot_img

Hot Topics